mipasetamab uzoptirine (ADCT-601)

News alerts, weekly reports and conference planners

Company:

Overland ADCT BioPharma

Drug class:

DNA replication inhibitor, AXL-targeted antibody-drug conjugate

Related drugs:

‹

›

AXL expression	Breast Cancer	AXL expression	Breast Cancer	ADCT-601 Sensitive: C3 – Early Trials ADCT-601 Sensitive : C3	ADCT-601 Sensitive: C3 – Early Trials ADCT-601 Sensitive : C3
AXL overexpression	Adenoid Cystic Carcinoma	AXL overexpression	Adenoid Cystic Carcinoma	ADCT-601 Sensitive: D – Preclinical ADCT-601 Sensitive : D	ADCT-601 Sensitive: D – Preclinical ADCT-601 Sensitive : D

Associations
(2)